Purification, cDNA cloning, and recombinant expression of chymotrypsin C from porcine pancreas

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 7, 2011, Pages 568-575

  Wang, Haibo ^a   Yuan, Duoduo ^a   Xu, Rong ^a   Chi, Cheng Wu ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

gene cloning; gene expression; porcine pancreas; sequence determination

Indexed keywords

CHYMOTRYPSIN; CHYMOTRYPSIN C; CHYMOTRYPSINOGEN; CHYMOTRYPSINOGEN C; COMPLEMENTARY DNA; METALLOPROTEINASE; PEPTIDYL LYS METALLOENDOPEPTIDASE; PEPTIDYL-LYS METALLOENDOPEPTIDASE; RECOMBINANT PROTEIN; SERINE PROTEINASE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL INCLUSION; CHEMISTRY; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; PANCREAS; SWINE;

AMINO ACID SEQUENCE; ANIMALS; CHYMOTRYPSIN; CHYMOTRYPSINOGEN; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ESCHERICHIA COLI; INCLUSION BODIES; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; PANCREAS; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES; SWINE;

ESCHERICHIA COLI; SUS;

EID: 79960132254     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr047     Document Type: Article

References (20)

1. Folk Je and Schirmer Ew. Chymotrypsin C. I. isolation of the zymogen and the active enzyme: preliminary structure and specificity studies. J Biol Chem 1965, 240: 181-192.
2. Iio-Akama K, Sasamoto H, Miyazawa K, Miura S and Tobita T. Active forms of chymotrypsin C isolated from autolyzed porcine pancreas glands. Biochim Biophys Acta 1985, 831: 249-256. (Pubitemid 15242683)
3. Tomomura A, Fukushige T, Noda T, Noikura T and Saheki T. Serum calcium-decreasing factor (caldecrin) from porcine pancreas has proteolytic activity which has no clear connection with the calcium decrease. FEBS Lett 1992, 301: 277-281.
4. Tomomura A, Fukushige T, Tomomura M, Noikura T, Nishii Y and Saheki T. Caldecrin proform requires trypsin activation for the acquisition of serum calcium-decreasing activity. FEBS Lett 1993, 335: 213-216. (Pubitemid 23350409)
5. Hasegawa H, Kido S, Tomomura M, Fujimoto K, Ohi M, Kiyomura M and Kanegae H, et al. Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity. J Biol Chem 2010, 285: 25448-25457.
6. Nemoda Z and Sahin-Tóth M. Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen. J Biol Chem 2006, 281: 11879-11886. (Pubitemid 43855449)
7. Szmola R and Sahin-Tóth M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y. Proc Natl Acad Sci USA 2007, 104: 11227-11232. (Pubitemid 47175123)
8. Rosendahl J, Witt H, Szmola R, Bhatia E, Ozsvári B, Landt O and Schulz HU, et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008, 40: 78-82.
9. Masson E, Chen JM, Scotet V, Le Maréchal C and Férec C. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet 2008, 123: 83-91.
10. Chen R, Pan S, Cooke K, Moyes KW, Bronner MP, Goodlett DR and Aebersold R, et al. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas 2007, 34: 70-79. (Pubitemid 46045723)
11. Tomomura A, Tomomura M, Fukushige T, Akiyama M, Kubota N, Kumaki K and Nishii Y, et al. Molecular cloning and expression of serum calcium-decreasing factor (caldecrin). J Biol Chem 1995, 270: 30315-30321. (Pubitemid 26006311)
12. Tomomura A, Akiyama M, Itoh H, Yoshino I, Tomomura M, Nishii Y and Noikura T, et al. Molecular cloning and expression of human caldecrin. FEBS Lett 1996, 386: 26-28. (Pubitemid 26144946)
13. Gomis-Rüth FX, Gómez-Ortiz M, Vendrell J, Ventura S, Bode W, Huber R and Avilés FX. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation. J Mol Biol 1997, 269: 861-880. (Pubitemid 27280852)
14. Chu H and Chi C. The isolation and crystallization of two trypsin inhibitors of low molecular weight from Mung bean. Acta Biochim Biophys Sin 1963, 3: 229-241.
15. Aronson NN, Jr and Barrett AJ. The specificity of cathepsin B. Hydrolysis of glucagon at the C-terminus by a peptidyldipeptidase mechanism. Biochem J 1978, 171: 759-765. (Pubitemid 8348753)
16. Kukor Z, Mayerle J, Krüger B, Tóth M, Steed PM, Halangk W and Lerch MM, et al. Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. J Biol Chem 2002, 277: 21389-21396. (Pubitemid 34952279)
17. Gratecos D and Desnuelle P. On a chymotrypsin C purified from autolyzed porcine pancreas. Biochem Biophys Res Commun 1971, 42: 857-864.
18. Peanasky RJ, Gratecos D, Baratti J and Rovery M. Mode of activation of N-terminal sequence of subunit II in bovine procarboxypeptidase A and of porcine chymotrypsinogen C. Biochim Biophys Acta 1969, 181: 82-92.
19. Tomomura A, Yamada H, Fujimoto K, Inaba A and Katoh S. Determination of amino acid sequence responsible for suppression of bone resorption by serum calcium-decreasing factor (caldecrin). FEBS Lett 2001, 508: 454-458. (Pubitemid 33135490)
20. Wang D, Bode W and Huber R. Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 Å resolution. J Mol Biol 1985, 185: 595-624. (Pubitemid 15241167)